|
ZNF689 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.15669712591671E-11 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.96229740526633E-11 |
| Normal-vs-Stage2 |
2.21099999999641E-05 |
| Normal-vs-Stage3 |
1.04629638286724E-11 |
| Normal-vs-Stage4 |
4.09694500547175E-12 |
| Stage1-vs-Stage2 |
8.342400E-02 |
| Stage1-vs-Stage3 |
2.238800E-01 |
| Stage1-vs-Stage4 |
7.878500E-02 |
| Stage2-vs-Stage3 |
2.359600E-02 |
| Stage2-vs-Stage4 |
1.039760E-02 |
| Stage3-vs-Stage4 |
4.478600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.8309023448212E-11 |
| Normal-vs-AfricanAmerican |
4.30260000000571E-05 |
| Normal-vs-Asian |
1.08730002779112E-09 |
| Caucasian-vs-AfricanAmerican |
4.405600E-01 |
| Caucasian-vs-Asian |
6.441400E-01 |
| AfricanAmerican-vs-Asian |
3.245800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.62012633811537E-14 |
| Normal-vs-Female |
5.94450044744121E-11 |
| Male-vs-Female |
3.658600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.57840423959033E-11 |
| Normal-vs-Age(41-60Yrs) |
3.24185123190546E-14 |
| Normal-vs-Age(61-80Yrs) |
1.14499520975642E-11 |
| Normal-vs-Age(81-100Yrs) |
5.997800E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.949200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.823600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.202600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.453000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.603000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.313400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.409570E-02 |
| Classical-VS-Follicular |
3.835800E-01 |
| Classical-VS-Other |
1.627160E-01 |
| Classical-VS-Normal |
8.56639981172691E-10 |
| Tall-VS-Follicular |
1.828010E-01 |
| Tall-VS-Other |
7.785000E-01 |
| Tall-VS-Normal |
1.85910176142556E-11 |
| Follicular-VS-Other |
3.891000E-01 |
| Follicular-VS-Normal |
1.70179981218155E-10 |
| Other-VS-Normal |
5.223600E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.26245713672324E-13 |
| Normal-vs-N1 |
1.54543045027822E-13 |
| N0-vs-N1 |
4.236900E-03 |
|
|
